15-41561231-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006293.4(TYRO3):c.229G>T(p.Val77Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006293.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYRO3 | NM_006293.4 | c.229G>T | p.Val77Leu | missense_variant | 2/19 | ENST00000263798.8 | NP_006284.2 | |
TYRO3 | NM_001330264.2 | c.94G>T | p.Val32Leu | missense_variant | 2/19 | NP_001317193.1 | ||
TYRO3 | XM_017022543.3 | c.229G>T | p.Val77Leu | missense_variant | 2/19 | XP_016878032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYRO3 | ENST00000263798.8 | c.229G>T | p.Val77Leu | missense_variant | 2/19 | 1 | NM_006293.4 | ENSP00000263798.3 | ||
TYRO3 | ENST00000559066.5 | c.94G>T | p.Val32Leu | missense_variant | 2/19 | 5 | ENSP00000454050.1 | |||
TYRO3 | ENST00000560992.1 | n.260G>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461886Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727246
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.229G>T (p.V77L) alteration is located in exon 2 (coding exon 2) of the TYRO3 gene. This alteration results from a G to T substitution at nucleotide position 229, causing the valine (V) at amino acid position 77 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.